Cat. No. 4706
Chemical Name: (1R,2R)-2-[(2S,4E,6Z,8R,9S,11R,13S,
Biological ActivityAntibiotic and antiangiogenic. Selectively inhibits threonyl-tRNA synthetase (ThrRS). Exhibits antiangiogenic activity in a mouse model of tumor angiogenesis. Induces apoptosis in capillary tube-forming endothelial cells; disrupts capillary tubes and inhibits their formation (IC50 = 0.8 nM in rat aorta). Induces the unfolded protein response (UPR) and apoptosis in oral cancer cells.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Sidhu et al (2015) Borrelidin induces the unfolded protein response in oral cancer cells and Chop-dependent apoptosis. ACS Med.Chem.Lett. 6 1122. PMID: 26617965.
Woolard et al (2011) Borrelidin modulates the alterntive splicing of VEGF in favour of anti-antiogenic isoforms. Chem.Sci. (2) 273. PMID: 22822423.
Kawamura et al (2003) Anti-angiogenesis effect of borrelidin are mediated through distinct pathways: threonyl-tRNA synthetase and caspases are independently involved in suppression of proliferation and induction of apoptosis in endothelial cells. J.Antibiot.(Tokyo). 56 709. PMID: 14563161.
Wakabayashi et al (1997) Borrelidin is an angiogenesis inhibitor; disruption of angiogenic capillary vessels in a rat aorta matrix culture model. J.Antibiot.(Tokyo). 50 671. PMID: 9315080.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Borrelidin from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Borrelidin, supplier, antibacterials, antibiotics, threonyl-tRNA, synthetase, ThrRS, antiangiogenics, capillary, capillaries, formation, inhibitors, inhibits, Tocris Bioscience, Other Synthase/Synthetase Inhibitor products
Find multiple products by catalog number
December 3 - 7, 2016
San Francisco, CA,